Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights - Takeaways - MDSpire

Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

  • By

  • Xue Ren

  • Feng Shang

  • Defu Yang

  • Ying Yan

  • Ying Xu

  • April 22, 2026

  • 0 min

Share

  • 1

    A 50-year-old male developed concurrent small cell lung cancer after glioblastoma recurrence, highlighting the rarity of dual malignancies.

  • 2

    The patient underwent individualized concurrent chemoradiotherapy, combining cranial radiotherapy with TMZ and etoposide plus platinum chemotherapy.

  • 3

    Treatment resulted in a partial response of the lung tumor and stable intracranial disease for 10 months, demonstrating effective dual tumor control.

  • 4

    The patient achieved a progression-free survival of 10 months for recurrent GBM and 13 months for SCLC, with an overall survival of 58 months.

  • 5

    This case suggests that tailored chemoradiotherapy strategies may provide meaningful survival benefits in patients with complex malignancies.

Original Source(s)

Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

  • by Xue Ren, Feng Shang, Defu Yang, Ying Yan, Ying Xu

  • April 22, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report